In a bid to settle thousands of lawsuits over its discontinued heartburn drug Zantac, Pfizer Inc. (NYSE:PFE) has agreed to ...
Pfizer will pay up to $250 million to settle more than 10,000 U.S. lawsuits over cancer risks associated with its ...
Pfizer has agreed to settle more than 10,000 lawsuits which alleged that the company failed to warn patients about possible cancer risks caused by the anti-heartburn medication Zantac. The ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Pfizer has agreed to pay up to $250mn to settle more than 10,000 US lawsuits over cancer risks associated ...
Der amerikanische Pharma-Riese Pfizer hat sich bereit erklärt, bis zu 250 Millionen Dollar (entspricht 230 Millionen Euro) zu zahlen, um mehr als 10.000 Klagen wegen Krebsrisiken im Zusammenhang ...
Pharmaceutical giant Pfizer has settled over 10,000 lawsuits accusing the company of concealing cancer risks associated with its ...
Pfizer has reached a major settlement in a legal battle concerning its recalled heartburn medication, Zantac. According to a Bloomberg report, Pfizer has agreed to settle over 10,000 lawsuits that ...
, opens new tab has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing people ...
Die Pfizer-Anleihe ist handelbar unter der WKN A19T6W bzw. der ISIN XS1738994596. Die Anleihe wurde am 19.12.2017 emittiert und hat eine Laufzeit bis 15.06.2043. Das Emissionsvolumen betrug bis zu ...
Der US-Konzern Pfizer befindet sich in Rechtsstreitigkeiten wegen des Sodbrenn-Medikaments Zantac. Nach Informationen der ...